Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Physician
Patient
Health Care Practitioner
Pharma / Biotech Industry
Other
Topics:
Radiation Oncology
•
Thoracic Malignancies
How would you manage out-of-field nodal recurrence of NSCLC post definitive CRT and adjuvant immunotherapy?
Answer from: Radiation Oncologist at Community Practice
Systemic therapy if distant disease. Radical chemoRT followed by immune therapy if solitary recurrence.
Comments
Radiation Oncologist at Yale School of Medicine
I agree. Before irradiating additional nodal disea...
Radiation Oncologist at Torrance Memorial Medical Center
Dr. @Park, would you ever just do SBRT rather than...
Radiation Oncologist at Yale School of Medicine
Rarely, but I've done low-dose SBRT (around 30-35 ...
10822
10834
10839
Sign in or Register to read more
20296
Related Questions
How would you treat a patient with newly diagnosed ALK+ Stage IIIB non-small cell lung cancer (NSCLC)?
Do you offer adjuvant durvalumab for stage I small cell lung cancer following SBRT or surgery?
How often, if ever, do patients with initially negative targetable mutation workup become positive later in recurrent lung cancer?
How would you approach SBRT in a pacemaker-dependent elderly patient with Stage I NSCLC whose SBRT plan Dmax exceeds the pacemaker tolerance?
What CTV expansions do you use for NSCLC with conventional chemoradiation and do you do different expansions based on specific histologies?
Does receipt of chemoimmunotherapy for LS-SCLC impact your recommendation for PCI?
For NSCLC patients treated with neoadjuvant chemoimmunotherapy and surgery with ypN2 disease, what factors would cause you to recommend PORT?
What are your top takeaways in Thoracic Cancers from ASTRO 2024?
How would you post-operatively manage a peripheral stage I small cell lung carcinoma s/p upfront wedge resection with an R1 microscopic positive margin along the staple line and visceral pleural invasion?
Do you perform EBUS-TBNA for staging in patients with biopsy proven malignant lung nodules with no lymphadenopathy on CT chest and PET scan?
I agree. Before irradiating additional nodal disea...
Dr. @Park, would you ever just do SBRT rather than...
Rarely, but I've done low-dose SBRT (around 30-35 ...